                               SEQUENCE LISTING

<110> F. HOFFMANN-LA ROCHE AG
      HOFFMANN-LA ROCHE INC.
      PTC THERAPEUTICS INC.
 
<120> COMPOUNDS FOR TREATING SPINAL MUSCULAR ATROPHY

<130> 036844-87629 (31539)

<140> PCT/US2014/043577
<141> 2014-06-23

<150> EP 13173487.3
<151> 2013-06-25

<160> 6     

<170> PatentIn version 3.5

<210> 1
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
gaaggaaggt gctcacatt                                                    19


<210> 2
<211> 22
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
tctttatgtt tttggcgtct tc                                                22


<210> 3
<211> 26
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe


<220>
<223> 5'-6FAM

<220>
<223> 3'-TAMRA

<400> 3
aaggagaaat gctggcatag agcagc                                            26


<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe


<220>
<223> 5'-VIC

<220>
<223> 3'-TAMRA

<400> 4
cgcctggtca ccagggctgc t                                                 21


<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
caacggattt ggtcgtattg g                                                 21


<210> 6
<211> 25
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
tgatggcaac aatatccact ttacc                                             25


